tiprankstipranks
Advertisement
Advertisement

Medcaw narrows losses as it pivots to Canadian gold project and AIM move

Story Highlights
  • Medcaw cut its 2025 pre-tax loss by 67%, bolstered liquidity with new convertible loan notes, and closed the year with stronger cash reserves despite remaining loss-making.
  • The company is pivoting to natural resources via a reverse takeover to secure 90% of Canada’s Eagle Lake Gold Project and plans a shift to AIM to access a broader mining investor base.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Medcaw narrows losses as it pivots to Canadian gold project and AIM move

Meet Samuel – Your Personal Investing Prophet

The latest update is out from Medcaw Investments PLC ( (GB:MCI) ).

Medcaw Investments reported a sharply reduced pre-tax loss of £144,478 for 2025, down 67% year on year, helped by the removal of prior impairment charges and the waiver of director fees. The company ended the year with £320,829 in cash, supported by £550,000 of unsecured convertible loan notes issued in September to cover corporate and transaction costs.

Strategically, the board has refined its focus toward natural resources and agreed binding heads of terms to acquire 90% of the Eagle Lake Gold Project in Ontario via a reverse takeover of Wedgetail Mining. The deal, alongside a proposed move from the Main Market to AIM and a planned placing, marks a major pivot that would give investors exposure to a gold asset in a stable mining region and is intended to underpin the company’s next growth phase despite an auditors’ emphasis on going concern.

More about Medcaw Investments PLC

Medcaw Investments Plc is a UK-listed investment company currently on the Main Market of the London Stock Exchange. The group is repositioning as a natural resources-focused vehicle, targeting Tier 1 mining jurisdictions and, subject to shareholder approval, plans to acquire a majority stake in the Eagle Lake Gold Project in Ontario, Canada.

Technical Sentiment Signal: Sell

For an in-depth examination of MCI stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1